JBGCX
Price
$44.41
Change
-$0.19 (-0.43%)
Updated
Apr 17 closing price
Net Assets
4.66B
VIGRX
Price
$181.21
Change
+$0.19 (+0.10%)
Updated
Apr 17 closing price
Net Assets
260.76B
Ad is loading...

JBGCX vs VIGRX

Header iconJBGCX vs VIGRX Comparison
Open Charts JBGCX vs VIGRXBanner chart's image
JHancock Blue Chip Growth C
Price$44.41
Change-$0.19 (-0.43%)
VolumeN/A
Net Assets4.66B
Vanguard Growth Index Investor
Price$181.21
Change+$0.19 (+0.10%)
VolumeN/A
Net Assets260.76B
JBGCX vs VIGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JBGCX vs. VIGRX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JBGCX is a Buy and VIGRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 261B vs. JBGCX (4.66B). VIGRX pays higher dividends than JBGCX: VIGRX (0.39) vs JBGCX (0.00). JBGCX was incepted earlier than VIGRX: JBGCX (10 years) vs VIGRX (32 years). JBGCX (1.89) is less costly to investors than VIGRX (0.17). JBGCX is a more actively managed with annual turnover of: 12.00 vs. VIGRX (5.00). JBGCX has a lower initial minimum investment than VIGRX: JBGCX (1000) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 6.01 vs. JBGCX (-2.92). VIGRX return over 5 years is better than : 99.21 vs. JBGCX (11.86).
JBGCXVIGRXJBGCX / VIGRX
Total Expense Ratio1.880.171,106%
Annual Report Gross Expense Ratio1.890.171,112%
Fund Existence10 years32 years-
Gain YTD-13.866-14.32697%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets4.66B261B2%
Annual Yield % from dividends0.000.39-
Returns for 1 year-2.926.01-48%
Returns for 3 years7.5230.3325%
Returns for 5 years11.8699.2112%
Returns for 10 years25.53223.8411%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCKT6.330.18
+2.93%
Rocket Pharmaceuticals
OVV33.820.72
+2.18%
Ovintiv
USAC25.220.29
+1.16%
USA Compression Partners LP
UNB31.340.35
+1.13%
Union Bankshares
VVOS2.100.02
+0.96%
Vivos Therapeutics